MTOR and cancer: As proteasomal activity is essential for ordered progression through the cell cycle (Koepp et al, 1999), and as the proteasome is regulated by mTOR signaling (Zhao et al, 2015) and is a potent drug target in human cancers (Goldberg, 2012), we decided to study the proteasome in more detail.